Detalhe da pesquisa
1.
Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia.
N Engl J Med
; 385(5): 406-415, 2021 07 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-34133856
2.
Efficacy and Safety of Extended Induction With Tofacitinib for the Treatment of Ulcerative Colitis.
Clin Gastroenterol Hepatol
; 20(8): 1821-1830.e3, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33127596
3.
Maintenance of Remission With Tofacitinib Therapy in Patients With Ulcerative Colitis.
Clin Gastroenterol Hepatol
; 20(1): 116-125.e5, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33039585
4.
Retrospective Database Analysis: Dose Escalation and Adherence in Patients Initiating Biologics for Ulcerative Colitis.
Dig Dis
; 40(5): 553-564, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34879378
5.
Therapeutic Drug Monitoring for Current and Investigational Inflammatory Bowel Disease Treatments.
J Clin Gastroenterol
; 55(3): 195-206, 2021 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32740098
6.
Tofacitinib Treatment Is Associated With Modest and Reversible Increases in Serum Lipids in Patients With Ulcerative Colitis.
Clin Gastroenterol Hepatol
; 18(1): 123-132.e3, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31077827
7.
Tofacitinib Induction Therapy Reduces Symptoms Within 3 Days for Patients With Ulcerative Colitis.
Clin Gastroenterol Hepatol
; 17(1): 139-147, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30012431
8.
A phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy.
Gastrointest Endosc
; 88(3): 427-437.e6, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29723512
9.
Tofacitinib, an Oral Janus Kinase Inhibitor: Analysis of Malignancy (Excluding Nonmelanoma Skin Cancer) Events Across the Ulcerative Colitis Clinical Program.
Inflamm Bowel Dis
; 27(6): 816-825, 2021 05 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-32766762
10.
Lipid Profiles in Patients With Ulcerative Colitis Receiving Tofacitinib-Implications for Cardiovascular Risk and Patient Management.
Inflamm Bowel Dis
; 27(6): 797-808, 2021 05 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-32870265
11.
Real-world Effectiveness of Advanced Therapies Among Patients With Moderate to Severe Ulcerative Colitis in the United States.
Inflamm Bowel Dis
; 26(6): 941-948, 2020 05 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31560046
12.
Treatment patterns among patients with moderate-to-severe ulcerative colitis in the United States and Europe.
PLoS One
; 15(1): e0227914, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31945774
13.
An economic evaluation of tofacitinib for the treatment of moderately-to-severely active ulcerative colitis: modeling the cost of treatment strategies in the United States.
J Med Econ
; 22(9): 859-868, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31012362
14.
Venous thromboembolic events in the tofacitinib ulcerative colitis clinical development programme.
Aliment Pharmacol Ther
; 50(10): 1068-1076, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31599001
15.
The Impact of Raising the Bar for Clinical Trials in Ulcerative Colitis.
J Crohns Colitis
; 13(9): 1217-1226, 2019 Sep 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-30879034
16.
Synchronous gastric and duodenal metastases from head and neck squamous cell carcinoma: a unique presentation of upper gastrointestinal bleeding.
Ann Gastroenterol
; 31(3): 381-383, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29720867
17.
Rectal Blue Nevus: Distinguishing Features of a Rare Entity.
ACG Case Rep J
; 3(4): e168, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28008401
18.
Letter: thromboembolic and cardiovascular events with tofacitinib in ulcerative colitis-two cases in real world clinical practice. Authors' reply.
Aliment Pharmacol Ther
; 51(11): 1209-1210, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32424928
19.
Gemcitabine, paclitaxel, and radiation for locally advanced pancreatic cancer: a Phase I trial.
Int J Radiat Oncol Biol Phys
; 54(1): 137-41, 2002 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-12182983
20.
SNAI2 modulates colorectal cancer 5-fluorouracil sensitivity through miR145 repression.
Mol Cancer Ther
; 13(11): 2713-26, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25249558